Janus Henderson Group PLC Humacyte, Inc. Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 36,900 shares of HUMA stock, worth $91,143. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,900
Previous 36,900
-0.0%
Holding current value
$91,143
Previous $186,000
66.13%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HUMA
# of Institutions
182Shares Held
60.7MCall Options Held
1.21MPut Options Held
877K-
Black Rock Inc. New York, NY7.14MShares$17.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$16.3 Million0.0% of portfolio
-
State Street Corp Boston, MA4.27MShares$10.5 Million0.0% of portfolio
-
Heights Capital Management, Inc San Francisco, CA4.03MShares$9.94 Million3.22% of portfolio
-
Woodline Partners LP San Francisco, CA3.95MShares$9.76 Million0.05% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $254M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...